ABUS logo

Arbutus Biopharma Corporation (ABUS) stock Relative Strength Index

14-Day RSI:

48.98+0.02(+0.04%)
November 28, 2025

Summary

  • As of today, ABUS stock 14-day relative strength index is 48.98, with the most recent change of +0.02 (+0.04%) on November 28, 2025.
  • ABUS stock current 14-day RSI indicates the stock is neither oversold nor overbought.

Performance

ABUS RSI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherABUStechnical indicators

ABUS 14-Day RSI Trends

PeriodPeriod14-Day RSI14-Day RSIPricePrice200-Day SMA200-Day SMA50-Day SMA50-Day SMA
1D1 Day+0.0%-2.1%+0.1%0.0%
1M1 Month-19.3%-8.7%+3.0%+3.3%
3M3 Months-1.3%+16.4%+9.5%+33.5%
6M6 Months-8.4%+28.5%+3.5%+35.0%
YTDYTD+21.6%+32.1%+6.1%+23.1%
1Y1 Year+38.2%+24.8%+8.2%+16.3%
5Y5 Years-18.9%+8.3%+44.7%+38.2%

ABUS 14-Day RSI Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month61.49-20.3%40.47+21.0%
3M3-Month87.41-44.0%40.47+21.0%
6M6-Month87.41-44.0%32.99+48.5%
1Y1-Year87.41-44.0%31.41+55.9%
3Y3-Year87.41-44.0%28.78+70.2%
5Y5-Year87.41-44.0%21.14+131.7%
All-TimeAll-Time91.89-46.7%0.00>+9999.0%

ABUS 14-Day RSI History

DateValue
2025
48.98(+21.6%)
2024
40.28(-47.8%)
2023
77.23(+82.8%)
2022
42.24(-13.2%)
2021
48.66(+10.2%)
2020
44.14(-36.1%)
2019
69.05(+69.1%)
2018
40.83(-14.3%)
2017
47.65(+35.1%)
DateValue
2016
35.26(+1.5%)
2015
34.74(-36.8%)
2014
54.95(+7.6%)
2013
51.08(-0.2%)
2012
51.16(+26.4%)
2011
40.46(-1.8%)
2010
41.19(-21.4%)
2009
52.38(+8.9%)
2008
48.11(+153.9%)
2007
18.95

FAQ

  • What is Arbutus Biopharma Corporation 14-day relative strength index?
  • What is the all-time high 14-day RSI for Arbutus Biopharma Corporation?

What is Arbutus Biopharma Corporation 14-day relative strength index?

The current 14-day RSI of ABUS is 48.98

What is the all-time high 14-day RSI for Arbutus Biopharma Corporation?

Arbutus Biopharma Corporation all-time high 14-day relative strength index is 91.89
On this page